Authors warn of some potential downsides to inform decision-making

Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery

Updated recommendations include alternative regimens for bacterial vaginosis, management of

Risk for serious infections increased for new users of adalimumab, infliximab versus etanercept; reduced with ustekinumab

Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses

Odds of psychological distress, smoking, suicidal intent reduced among transgender and gender-diverse adults assigned male at birth

Novel simplified scoring system and associated AI model could help dermatologists quickly evaluate psoriasis severity

Johnson & Johnson said it was still investigating how traces of benzene were discovered in the sunscreens

Case report shows benefit for cemiplimab in patient with locally advanced ulcerated cSCC, two infiltrative BCCs

Patient presented for examination of facial and ocular discoloration; eight-year history of minocycline use for acne vulgaris identified

History of psoriasis consistently reported, whereas history of atopic dermatitis is not

Pronounced lag in antibody production after the first dose found versus noncancer controls

Authors say patients with androgenetic alopecia may need psychological, psychosocial support

However, less than one-third of teens reported discussions about sexual and reproductive health topics other than puberty at most recent visit

Decrease seen for 11 of the 19 most common cancers among men and for 14 of the 20 most common cancers among women

Tumors involving the scalp/neck carry the highest cumulative Merkel cell carcinoma-specific mortality incidence

Most common reactions include delayed large local reactions, local injection site reactions, urticaria, and morbilliform eruptions

Prevalence similar for women and men, highest among Whites, not significantly different from 2003

Men with rosacea have twice the risk for self-reported migraine versus those without rosacea

Subgroup analysis by age shows point estimate higher for adults aged 20 to 49 years than for those aged 50 years and older

Mycological cure rate was 69.9 percent; complete cure seen for 4.5 percent, with few adverse events